Clinical Trial

Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This randomized Phase III study aims to show major complication rate of hypofractionation radiation therapy is not inferior, compared to conventional fractionation radiation therapy in breast cancer patients undergoing mastectomy and reconstruction surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-02-15.
Trial Details
NCT Number NCT05253170
Lead Sponsor Seoul National University Bundang Hospital
Collaborators: Seoul National University Hospital
Conditions Breast Cancer, Radiotherapy; Complications
Enrollment 622 participants
Start Date 2022-04-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-03-11